Citation: C. Efthymiopoulos et al., PHARMACOKINETICS OF GREPAFLOXACIN AFTER ORAL-ADMINISTRATION OF SINGLEAND REPEAT DOSES IN HEALTHY-YOUNG MALES, Clinical pharmacokinetics, 33, 1997, pp. 1-8
Citation: C. Efthymiopoulos et al., EFFECT OF FOOD AND GASTRIC PH ON THE BIOAVAILABILITY OF GREPAFLOXACIN, Clinical pharmacokinetics, 33, 1997, pp. 18-24
Authors:
EFTHYMIOPOULOS C
BRAMER SL
MAROLI A
FLAHERTY JF
WOLFE E
BASS N
SOMBERG K
Citation: C. Efthymiopoulos et al., GREPAFLOXACIN PHARMACOKINETICS IN INDIVIDUALS WITH HEPATIC-DYSFUNCTION, Clinical pharmacokinetics, 33, 1997, pp. 25-31
Authors:
EFTHYMIOPOULOS C
BRAMER SL
MAROLI A
GAMBERTOGLIO JG
Citation: C. Efthymiopoulos et al., EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF GREPAFLOXACIN, Clinical pharmacokinetics, 33, 1997, pp. 32-38
Citation: B. Odoherty et al., RANDOMIZED, DOUBLE-BLIND, COMPARATIVE-STUDY OF GREPAFLOXACIN AND AMOXICILLIN IN THE TREATMENT OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA, Journal of antimicrobial chemotherapy, 40, 1997, pp. 73-81
Citation: H. Abdelnabi et al., LOCALIZATION OF COLORECTAL-CARCINOMA WITH A COMBINATION OF IN-111 CYT-103 AND IN-111 CYT-372 MONOCLONAL-ANTIBODIES, The Journal of nuclear medicine, 35(5), 1994, pp. 160000011-160000011